Novartis to buy U.S. biotech firm Avidity Biosciences for about $12 billion in cash

TORRE

Oct 26, 2025 - 22:00

0

Novartis to buy U.S. biotech firm Avidity Biosciences for about $12 billion in cash

Novartis will pay Avidity shareholders $72 a share in cash, a premium of 46% to the company's Friday closing price.

TORRE

Related Posts

Talks between Putin aide and White House enter third day

Talks between Putin aide and White House enter third day

TORRE Oct 26, 2025 0

Novartis is in talks to buy U.S. biotech firm Avidity Biosciences for more than $70 a share, Bloomberg News reports

Novartis is in talks to buy U.S. biotech firm Avidity B...

TORRE Oct 26, 2025 0

These 4 traits help successful people achieve their goals more often than most, Ivy League psychologist says: 'Stop writing in your journal'

These 4 traits help successful people achieve their goa...

TORRE Oct 26, 2025 0

Thailand and Cambodia ink ceasefire deal (VIDEO)

Thailand and Cambodia ink ceasefire deal (VIDEO)

TORRE Oct 26, 2025 0

The left’s forgotten killers: How America’s radicals killed – and became heroes instead of criminals

The left’s forgotten killers: How America’s radicals ki...

TORRE Oct 26, 2025 0

Chinese and U.S. Officials Reach Framework of a Trade Deal

Chinese and U.S. Officials Reach Framework of a Trade Deal

TORRE Oct 26, 2025 0